Using Fuzzy Logic to Adjust Plasma Concentration Based on a Two-Compartment Pharmacokinetic Model

Article Preview

Abstract:

In this paper, a closed-loop control system was developed using fuzzy logic to adapt the parameters of a pharmacokinetic (PK) model. The system is based on a two-compartment PK model with first-order rate process of oral administration. The fuzzy logic adaptation scheme uses the error and the change in error as the input variables. The output variable of the fuzzy controller is the scaling factor to adjust the PK parameter. The fuzzy controller adjusted the real situation concentration to the reference value derived from the parameters of population mean data according to the established rule-base. The simulation results show that the controller provides good performance to adjust the concentration with the reference values.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

1171-1174

Citation:

Online since:

July 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] A. Torres and J.J. Nieto, Fuzzy Logic in Medicine and Bioinformatics, J. Biomed. Biotechnol, 2006 (2006) 1-7.

Google Scholar

[2] S.S. Godil, M.S. Shamim, S.A. Enam, and U. Qidwai, Fuzzy Logic: A simple" solution for complexities in neurosciences, Surg. Neurol. Int, 2: 24 (2011).

DOI: 10.4103/2152-7806.77177

Google Scholar

[3] C.C. Lee, Fuzzy logic in control systems: fuzzy logic controller-part I, Systems, Man and Cybernetics, IEEE Transactions on, 20: 2 (1990) 404-418.

DOI: 10.1109/21.52551

Google Scholar

[4] S.E. Kern, J.O. Johnson and D.R. Westenskow, Fuzzy logic for model adaptation of a pharmacokinetic-based closed loop delivery system for pancuronium, Artif. Intell. Med, 11: 1 (1997) 9–31.

DOI: 10.1016/s0933-3657(97)00022-5

Google Scholar

[5] L. Shargel, S. Wu-Pong and A. B. C. Yu, Applied biopharmaceutics and pharmacokinetics, McGraw-Hill Companies, New York, (2005).

Google Scholar

[6] G. L. Dickinson, S. Rezaee, N. J. Proctor, M. S. Lennard, G. T. Tucker and A. Rostami-Hodjegan, Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application, J. Clin. Pharmacol, 47 (2007).

DOI: 10.1177/0091270006294279

Google Scholar